Episode 53: Christian Angermayer - Founder of Apeiron Investment Group
About this episode
Amir Fischer interviews Christian Angermayer about his entrepreneurial journey and investments in biotech and psychedelics.
This week on Generating Alpha, I sat down with Christian Angermayer — serial entrepreneur, biotech pioneer, and founder of Apeiron Investment Group, one of the most unconventional private investment firms in the world. Christian grew up in a small town in Bavaria and dropped out of university at 20 to co-found Ribopharma, a biotech built on groundbreaking RNA interference technology. He sold it to Alnylam Pharmaceuticals before turning 25, and has spent the two decades since founding three unicorns, backing four more, and completing over 50 IPOs and M&A transactions across life sciences, fintech, crypto, and frontier technology. His most defining chapter has been psychedelics. At a time when psilocybin was still considered fringe science, Christian seed-funded Compass Pathways and founded atai Life Sciences — taking it public on Nasdaq at a $3.2 billion valuation — almost single-handedly transforming psychedelic medicine from a relic of the 1960s into one of the most compelling frontiers in modern psychiatry. His latest bet is just as bold. This past Friday, Enhanced Games — his performance-enhancing-drug-permitted alternative to the Olympics that doubles as a performance…
More episodes of Generating Alpha Podcast
- Episode 54: Michael Shvo - Chairman and CEO of SHVO
- Episode 51: Fabrice Grinda - Founding Partner of FJ Labs
- Episode 50: Ian Livingstone - Co-Founder of London Regional Properties
- Episode 49: Yoni Assia - Co-Founder and CEO of eToro
- Episode 48: Dmitry Balyasny - Managing Partner and CIO of Balyasny Asset Management
- Episode 47: Pete Muller - Founder of PDT Partners
Explore listener stats, chart rankings, contacts and more on the Generating Alpha Podcast podcast page.